Sai Life Sciences Ltd share price logo

Sai Life Sciences Ltd Share Price

(SAILIFE)

₹7072.08%

as on 04:01PM, 22 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Sai Life Sciences Ltd Performance

  • Day's Low

    Day's High

    ₹702.55
    Day's Price Range
    ₹734
  • 52 Week's Low

    52 Week's High

    ₹636.1
    52-Week Price Range
    ₹808.8
1 Month Return-2.24 %
3 Month Return+ 4.31 %
1 Year Return-5.58 %
Previous Close₹722.00
Open₹725.50
Volume4.69L
Upper Circuit₹866.40
Lower Circuit₹577.60
Market Cap₹15,048.02Cr

Sai Life Sciences Ltd Fundamentals

P/E Ratio

45.72

PEG Ratio

2.95

Market Cap

₹1,539.74 Cr

P/B Ratio

3.78

EPS

24.88

Dividend Yield

0.43

Sector

Pharmaceuticals

ROE

8.98

Sai Life Sciences Ltd Analyst Rating

based on 4 analysts

BUY

50.00%

Buy

25.00%

Hold

25.00%

Sell

Based on 4 analysts offering long term price targets for Sai Life Sciences Ltd. An average target of ₹777.5

Source: S&P Global Market Intelligence

Sai Life Sciences Ltd Share analysis

Sai Life Sciences Ltd price forecast by 4 analysts

Upside of7.69%

High

₹865

Target

₹777.50

Low

₹700

Sai Life Sciences Ltd target price ₹777.5, a slight upside of 7.69% compared to current price of ₹707. According to 4 analysts rating.

Source: S&P Global Market Intelligence

Key events for Sai Life Sciences Ltd

  • Sai Life Sciences Ensures SEBI Compliance - 11 Apr, 2025

    Sai Life Sciences Ltd. has submitted a compliance certificate under SEBI regulations for the quarter ended March 31, 2025, confirming proper handling of securities.
  • Sai Life Sciences Launches Peptide Research Center - 03 Apr, 2025

    Sai Life Sciences has established a dedicated Peptide Research Center in Hyderabad to enhance capabilities in peptide synthesis and support next-generation therapeutics. This facility aims to meet the rising demand for peptide-based therapeutics, integrating advanced technologies to improve precision and efficiency in drug development.
  • Sai Life Sciences Target Price Set at Rs 720 - 18 Mar, 2025

    Jefferies highlights Sai Life Sciences as a strong innovator-focused CDMO with a healthy pipeline and predicts a revenue CAGR of 15% and EBITDA CAGR of 29% over FY25-27. The target price is set at Rs 720, reflecting a premium valuation due to superior growth prospects, though current valuations may limit upside potential.
  • Jefferies Initiates Coverage on Sai Life Sciences - 17 Mar, 2025

    Jefferies has initiated coverage on Sai Life Sciences with a Hold rating and a target price of Rs 720, citing high valuations. The stock closed at Rs 703.80, with 4% of equity becoming tradable as the lock-in period ends.
  • Sai Life Sciences Expects Growth in CRO Business - 13 Mar, 2025

    Krishna Kanumuri, MD and CEO of Sai Life Sciences, expressed confidence in the company's contract research organization (CRO) business, anticipating growth as its collaboration with Schrödinger progresses.

Insights on Sai Life Sciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 11.72% to 12.36% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 10.19% to 11.54% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 35.24% to 35.17% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SAILIFE stock has moved down by -6.4%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 41.09% to 39.21% in Mar 2025 quarter

Sai Life Sciences Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹383.63Cr (-)₹439.21Cr (↑14.49%)₹279.72Cr (↓36.31%)₹395.56Cr (↑41.41%)₹439.78Cr (↑11.18%)
Net Income₹39.61Cr (-)₹56.13Cr (↑41.71%)-₹13.50Cr (↓124.05%)₹41.51Cr (↓407.48%)₹53.85Cr (↑29.73%)
Net Profit Margin10.33% (-)12.78% (↑23.72%)-4.83% (↓137.79%)10.49% (↓317.18%)12.24% (↑16.68%)
Value in ₹ crore
Details2021202220232024
Total Assets₹1,816.48Cr (-)₹2,105.89Cr (↑15.93%)₹2,185.04Cr (↑3.76%)₹2,291.05Cr (↑4.85%)
Total Liabilities₹948.96Cr (-)₹1,214.86Cr (↑28.02%)₹1,272.31Cr (↑4.73%)₹1,279.85Cr (↑0.59%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹108.75Cr (-)-₹25.94Cr (↓123.85%)₹88.38Cr (↓440.71%)₹221.47Cr (↑150.59%)₹250.64Cr (↑13.17%)

Sai Life Sciences Ltd Index Inclusions

BSE IPO

₹13,919.15

0.39 (53.78%)

Nifty Smallcap 250

₹15,878.05

0.8 (126.2%)

Nifty 500

₹22,085.15

0.36 (79.4%)

BSE Healthcare

₹42,285.05

0.75 (315.43%)

Nifty MidSmallcap 400

₹18,543.20

0.83 (153%)

BSE Small-Cap

₹49,143.12

0.82 (397.7%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

Sai Life Sciences Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
35.17%
0.00
Foreign Institutions
12.36%
0.00
Mutual Funds
11.54%
0.00
Retail Investors
39.21%
0.00
Others
1.72%
0.00

Sai Life Sciences Ltd Key Indicators

Details20202021202220232024
Return On Equity %10.617.860.52.699.9
Details2021202220232024
Return On Assets %3.360.30.463.61

Sai Life Sciences Ltd Valuation

Sai Life Sciences Ltd in the last 5 years

  • Overview

  • Trends

Lowest (17.68x)

April 9, 2025

Today (19.94x)

April 21, 2025

Industry (53.29x)

April 21, 2025

Highest (21.54x)

January 3, 2025

LowHigh

Sai Life Sciences Ltd Earnings and Dividends

  • Sai Life Sciences Ltd Earnings Results

    Sai Life Sciences Ltd’s net profit jumped 35.95% since last year same period to ₹53.85Cr in the Q3 2024-2025. On a quarterly growth basis, Sai Life Sciences Ltd has generated 29.73% jump in its net profits since last 3-months.

    Read More about Earnings Results

Sai Life Sciences Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Sai Life Sciences Ltd is currently in a Bearish trading position according to technical analysis indicators.

Sai Life Sciences Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹1,539.74 Cr15.93%0.69₹21 Cr₹304 Cr
NA₹88.06 Cr50.7%0.62-₹5 Cr₹104 Cr
NA₹184.02 Cr107.19%0.58NANA
NA₹132.78 Cr10.96%0.72-₹10 Cr₹368 Cr
NA₹100.70 Cr42.74%0.55NANA

About Sai Life Sciences Ltd

Sai Life Sciences Limited was originally incorporated as Sai Dru Syn Laboratories Limited as a Public Limited Company dated January 25 1999 issued by the Registrar of Companies Andhra Pradesh at Hyderabad. The Company received the Certificate of Commencement of Business from Registrar of Companies Andhra Pradesh on February 17 1999. Subsequently the Company name was changed from Sai Dru Syn Laboratories Limited to Sai Life Sciences Limited dated December 16 2003.Thereafter the name of the Company was changed from Sai Life Sciences Limited to Sai Advantium Pharma Limited dated August 30 2006 issued by the Registrar of Companies Andhra Pradesh. Subsequently the Company name was changed from Sai Advantium Pharma Limited to Sai Life Sciences Limited and a fresh Certificate of Incorporation dated May 28 2012 was issued by the Registrar of Companies Andhra Pradesh at Hyderabad.The Company is an innovatorfocused contract research development and manufacturing organization CRDMO. The Company provide endtoend services across the drug discovery development and manufacturing value chain for small molecule NCE to global pharmaceutical innovators companies and biotechnology firms. It possess both a discovery / contract research and b CMC / CDMO capabilities.Through the Scheme of Amalgamation Prasad Drugs Limited was merged into the Company in 2004. The Company acquired Merrifield Pharma Private Limited in 2006. Later the Company opened new areas of biology facility in Watertown Greater Boston MA U.S.A. for innovative and creative smallmolecule drugs in 2019. It launched Sai Nxt an initiative to transform the organization into a new generation CDMO in 2020. It further added cellular analysis platforms at its discovery biology facility in Cambridge Massachusetts USA.In 2021 the Company opened a new discovery biology facility at Unit II Plant in Hyderabad. In 2022 it opened the first set of new disconvery chemistry labs at Unit III Plant Hyderabad. In 2023 the Company opened high potency API manufacturing block at Unit IV Bidar Facility and has started API developability formulations DF capabilities at Unit II Hyderabad in 2024.The Company is proposing to raise money from public through IPO by issue and allotment of 61573120 Equity Shares through Offer for Sale and a Fresh Issue aggregating to Rs 800 Crores Equity Shares..

Revenue: ₹439.78Cr as on December 2024 (Q4 24)
Net Profit: ₹53.85Cr as on December 2024 (Q4 24)
Listing date: 18 Dec, 2024
Chairperson Name: Ranga Raju Kanumuri
OrganisationSai Life Sciences Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Sai Life Sciences Ltd

What is Sai Life Sciences Ltd price today?

Sai Life Sciences Ltd share price today stands at ₹707, Open: ₹725.5, Previous Close: ₹722, High: ₹734, Low: ₹702.55, 52 Week High: ₹808.8, 52 Week Low: ₹636.1.

How to Buy Sai Life Sciences Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Sai Life Sciences Ltd shares

What are today's traded volumes of Sai Life Sciences Ltd?

Today's traded volume of Sai Life Sciences Ltd(SAILIFE) is 4.69L.

What is today's market capitalisation of Sai Life Sciences Ltd?

Today's market capitalisation of Sai Life Sciences Ltd(SAILIFE) is ₹15048.02Cr.

What is the 52 Week High and Low Range of Sai Life Sciences Ltd?

Sai Life Sciences Ltd (SAILIFE)
Price
52 Week High
₹808.8
52 Week Low
₹636.1

How much percentage Sai Life Sciences Ltd is down from its 52 Week High?

Sai Life Sciences Ltd (SAILIFE) share price is ₹707. It is down -12.59% from its 52 Week High price of ₹808.8

How much percentage Sai Life Sciences Ltd is up from its 52 Week low?

Sai Life Sciences Ltd (SAILIFE) share price is ₹707. It is up 11.15% from its 52 Week Low price of ₹636.1